Twinbeech Capital LP purchased a new position in BioMarin Pharmaceutical Inc. ( NASDAQ:BMRN – Get Rating ) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 161,923 shares of the biotechnology company's stock, valued at approximately $13,726,000. Twinbeech Capital LP owned approximately 0.09% of BioMarin Pharmaceutical as of its most recent SEC filing. A number of other hedge funds and other institutional investors have also bought and sold shares of BMRN.

https://www.dailypolitical.com/2023/03/09/twinbeech-capital-lp-makes-new-investment-in-biomarin-pharmaceutical-inc-nasdaqbmrn.html

#dailypolitical